Related references
Note: Only part of the references are listed.Establishment of patient-derived organoid models of lower-grade glioma
Kalil G. Abdullah et al.
NEURO-ONCOLOGY (2022)
Targeting immunoliposomes to EGFR-positive glioblastoma
B. Kasenda et al.
ESMO OPEN (2022)
Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
Virginia Aragon-Sanabria et al.
CLINICAL CANCER RESEARCH (2022)
Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas
Gi-Ming Wang et al.
NEURO-ONCOLOGY (2022)
Molecular Biomarkers in Glioblastoma: A Systematic Review and Meta-Analysis
Heena Sareen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma
Lingli Gong et al.
CELL DEATH DISCOVERY (2022)
EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures
Suhas V. Vasaikar et al.
BRITISH JOURNAL OF CANCER (2021)
Updated Insights on EGFR Signaling Pathways in Glioma
Alexandru Oprita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
Alexander Ou et al.
CANCERS (2021)
A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures
Naga Prathyusha Maturi et al.
GLIA (2020)
Inhibition of MGMT-mediated autophagy suppression decreases cisplatin chemosensitivity in gastric cancer
Yuanyuan Lei et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation
Caroline von Achenbach et al.
MOLECULAR CANCER THERAPEUTICS (2020)
EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide
Iwona Anna Ciechomska et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
MGMT expression affects the gemcitabine resistance of pancreatic cancer cells
Yu Shi et al.
LIFE SCIENCES (2020)
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Domenico Ribatti et al.
TRANSLATIONAL ONCOLOGY (2020)
Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics
Abhimanyu Thakur et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
The landscape of the mesenchymal signature in brain tumours
Jinan Behnan et al.
BRAIN (2019)
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
Raghupathy Vengoji et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
Maryam Moradi Binabaj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis
Yi-Li Lin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
Zhenyi An et al.
ONCOGENE (2018)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Survival in glioblastoma: a review on the impact of treatment modalities
P. D. Delgado-Lopez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope
Andrew C. Phillips et al.
MOLECULAR CANCER THERAPEUTICS (2016)
BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells
Iwona Anna Ciechomska et al.
SCIENTIFIC REPORTS (2016)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles
Lei Wang et al.
JOURNAL OF DRUG TARGETING (2015)
The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
Yuan Xie et al.
EBIOMEDICINE (2015)
Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
Emily Padfield et al.
FRONTIERS IN ONCOLOGY (2015)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Subtyping of gliomas of various WHO grades by the application of immunohistochemistry
Svetlana N. Popova et al.
HISTOPATHOLOGY (2014)
Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma
Roshan Mahabir et al.
NEURO-ONCOLOGY (2014)
Subclassification of Newly Diagnosed Glioblastomas through an Immunohistochemical Approach
Siobhan Conroy et al.
PLOS ONE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
EGFR Phosphorylates Tumor-Derived EGFRvIll Driving STAT3/5 and Progression in Glioblastoma
Qi-Wen Fan et al.
CANCER CELL (2013)
Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
U. D. Kahlert et al.
CANCER LETTERS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs
Daniel Lakens
FRONTIERS IN PSYCHOLOGY (2013)
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
Christoph Mamot et al.
LANCET ONCOLOGY (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Epidermal Growth Factor Receptor Expression Identifies Functionally and Molecularly Distinct Tumor-Initiating Cells in Human Glioblastoma Multiforme and Is Required for Gliomagenesis
Stefania Mazzoleni et al.
CANCER RESEARCH (2010)
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Tiziano Di Tomaso et al.
CLINICAL CANCER RESEARCH (2010)
STAT3 tyrosine phosphorylation influences survival in glioblastoma
Peter Birner et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller et al.
NATURE REVIEWS NEUROLOGY (2010)
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
Andreana L. Rivera et al.
NEURO-ONCOLOGY (2010)
Oligodendroglioma cell lines containing t(1;19)(q10;p10)
John J. P. Kelly et al.
NEURO-ONCOLOGY (2010)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?
Georg Karpel-Massler et al.
MOLECULAR CANCER RESEARCH (2009)
Oncogenic EGFR Signaling Networks in Glioma
Paul H. Huang et al.
SCIENCE SIGNALING (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Ubiquitination and degradation of mutant p53
Natalia Lukashchuk et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
Hongbing Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers - Implications for combination therapy with monoclonal antibody 806
Hui K. Gan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Assessment of pluripotency and multilineage differentiation potential of NTERA-2 cells as a model for studying human embryonic stem cells
Rajarshi Pal et al.
CELL PROLIFERATION (2006)
Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) - phase I/II trial: study protocol
Stephanie E. Combs et al.
BMC CANCER (2006)
Preclinical analysis of the analinoquinazoline AG14781 a specific small molecule inhibitor of EGF receptor tyrosine kinase
AG Ellis et al.
BIOCHEMICAL PHARMACOLOGY (2006)
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells
YH Loh et al.
NATURE GENETICS (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma
DA Reardon et al.
CLINICAL CANCER RESEARCH (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity
RM Perera et al.
CLINICAL CANCER RESEARCH (2005)
Anti-epidermal growth factor receptor monoclonal antibody cetuximab augments radiation effects in glioblastoma multiforme in vitro and in vivo
JL Eller et al.
NEUROSURGERY (2005)
Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging
R Saito et al.
CANCER RESEARCH (2004)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478
TG Johns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
